Pharmacokinetics of Ibuprofen Enantiomers in Children with Cystic Fibrosis
- 1 August 2000
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 40 (8) , 861-868
- https://doi.org/10.1177/00912700022009594
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The pharmacokinetics of ibuprofen suspension, chewable tablets, and tablets in children with cystic fibrosisThe Journal of Pediatrics, 1999
- Effect of clofibrate on the chiral inversion of ibuprofen in healthy volunteers*Clinical Pharmacology & Therapeutics, 1998
- Effect of High-Dose Ibuprofen in Patients with Cystic FibrosisNew England Journal of Medicine, 1995
- Ibuprofen in children with cystic fibrosis: Pharmacokinetics and adverse effectsThe Journal of Pediatrics, 1991
- Pharmacokinetics of S(+)- and R(−)-ibuprofen in volunteers and first clinical experience of S(+)-ibuprofen in rheumatoid arthritisEuropean Journal of Clinical Pharmacology, 1990
- Enantioselective Aspects of Drug Action and Disposition: Therapeutic PitfallsJournal of Pharmaceutical Sciences, 1989
- Cystic fibrosis: enhanced theophylline metabolism may be linked to the diseaseClinical Pharmacology & Therapeutics, 1988
- Antibiotic Pharmacokinetics in Cystic FibrosisClinical Pharmacokinetics, 1987
- Stereoselective disposition of ibuprofen enantiomers in man.British Journal of Clinical Pharmacology, 1985
- Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (—)-isomerJournal of Pharmacy and Pharmacology, 1976